Clinical Trial

HS-10542 Study in Healthy Participants

Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated June 26, 2025 (before its estimated December 4, 2025 completion). Its status may not reflect the trial's current state.
Summary
This is a randomized, double-blind, placebo-controlled, dose escalation phase I clinical study to evaluate the safety, tolerability, pharmacokinetics, and the food effect on the pharmacokinetics of HS-10542 in healthy participants.
Trial Details
NCT Number NCT07040046
Lead Sponsor Jiangsu Hansoh Pharmaceutical Co., Ltd.
Conditions Healthy
Enrollment 100 participants
Start Date 2025-05-16
Primary Completion 2025-12-04 (estimated)
Study Completion 2026-03-31 (estimated)
Updated on ClinicalTrials.gov 2025-06-26